Ser191

Site Information
RsRsRDRsHERNRDR SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 470365

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	cervical cancer ( 1 ) , cervical adenocarcinoma ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 3 ) , HeLa S3 (cervical) ( 1 ) , Jurkat (T lymphocyte) ( 2 )

References
1	Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3 20068231 Curated Info
2	Possemato A (2009) CST Curation Set: 5911; Year: 2009; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Curated Info
3	Olsen JV, et al. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-48 17081983 Curated Info